ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis

Jian Liu(Edinburgh College), Francesco J. DeMayo(National Institute of Environmental Health Sciences), Farrah Kheradmand(Michael E. DeBakey VA Medical Center), Chad J. Creighton(Baylor College of Medicine), Weiwen Long(Wright State University), Tenghui Chen(The University of Texas MD Anderson Cancer Center), Nili Jin(Baylor College of Medicine), Ignacio I. Wistub(The University of Texas MD Anderson Cancer Center), Yiqun Zhang(Tongji University), Jianqiang Mao(Baylor College of Medicine), Ximing Tang(The University of Texas MD Anderson Cancer Center), Sung-Nam Cho(The University of Texas MD Anderson Cancer Center), Bindu Akkanti(The University of Texas Health Science Center at Houston)
Cell Reports
March 1, 2015
10.1016/j.celrep.2015.02.014
Cited by 93

Related Papers

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
Comprehensive molecular characterization of urothelial bladder carcinoma
|Nature|2014|3.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k